Market Share of Middle East and Africa Diabetes Drugs Industry
The Middle East and African diabetes drugs market is moderately fragmented, with major manufacturers, namely Eli Lilly, Sanofi, Novo Nordisk, AstraZeneca, etc., holding a presence in the region and other regional players. A major share of the market is held by manufacturers, concomitant with strategy-based M&A operations, and constantly entering the market to generate new revenue streams and boost existing ones. These measures taken by the market players are expected to ensure a competitive marketplace, therefore forcing the companies to experiment with more new technologies.
Middle East and Africa Diabetes Treatment Market Leaders
-
Boehringer Ingelheim
-
Astrazeneca
-
Eli Lilly
-
Sanofi
-
Novo Nordisk
*Disclaimer: Major Players sorted in no particular order
